China diagnostic reagent industry report,2011 2012

2,263 views
2,208 views

Published on

Published in: Education, Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
2,263
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
10
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

China diagnostic reagent industry report,2011 2012

  1. 1. China Diagnostic Reagent Industry Report, 2011-2012 Oct. 2011
  2. 2. <ul><li>This report </li></ul><ul><li>Analyzes the operating environment of China diagnostic reagent industry </li></ul><ul><li>Focuses on the development of diagnostic reagent industry </li></ul><ul><li>Highlights the operation of major diagnostic reagent manufacturers in China. </li></ul>Please visit our website to order this report and find more information about other titles at www.researchinchina.com Related Products China Health Management Survey Report, 2011 China Oral Hypoglyceimic Agents (OHAs) Industry Report, 2010 China Interventional Cardiovascular Device Industry Report, 2010 China Insulin Industry Report, 2010 China Animal Vaccine Industry Report, 2010-2011 China Blood Products Industry Report, 2010-2011
  3. 3. <ul><li>Market Size and Growth Rate of In Vitro Diagnostic Industry in </li></ul><ul><li>China, 2007-2014E </li></ul><ul><li>Source: ResearchInChina </li></ul><ul><li>As far as market segment is concerned, China’s IVD reagents are </li></ul><ul><li>still focused on lower-end clinical immunology and clinical chemistry </li></ul><ul><li>diagnostic reagents for now, with separate market sizes up to </li></ul><ul><li>RMB3.4 billion and RMB3.1 billion in 2010, taking 35% and 32% of </li></ul><ul><li>China’s IVD reagent market respectively. In recent years, along with </li></ul><ul><li>the launch of nucleic acid blood screening pilot, nucleic acid </li></ul><ul><li>diagnostics market has been further expanded, as of the end of </li></ul><ul><li>2010, there had already been six pharmaceutical factories to declare </li></ul><ul><li>nucleic acid blood screening reagents to the State Food and Drug </li></ul><ul><li>Administration (SFDA), namely, KHB, Da An Gene, Haoyuan </li></ul><ul><li>Biotech, PG Biotech (later acquired by QIAGEN), Roche and </li></ul><ul><li>Novartis Diagnostics, which will benefit from the nucleic acid blood </li></ul><ul><li>screening pilot and subsequent marketing. </li></ul><ul><li>   </li></ul>Abstract Diagnostic reagent can be divided into in vitro diagnostic (IVD) reagent and in vivo diagnostic reagent, wherein the former always holds a larger market share in China, accounting for 92.6% in the overall market for diagnostic reagents in 2010. Despite a late start, China’s IVD reagent industry has achieved fast development, benefiting from the improved medical care spending, support of national policies, etc. The market size of China’s IVD industry reached RMB12.1 billion in 2010, with the compound annual growth rate of up to 13.8% from 2007 to 2010, higher than the global growth of 12.6% over the corresponding period. Moreover, considering the large population base, improved economy, etc., China’s IVD reagent industry possesses huge potential for future growth, which is expected to hit RMB23.2 billion in 2014. IVD products mainly consist of diagnostic reagents and instruments. In 2010, the market size of IVD reagents climbed 13.3% YoY to RMB9.7 billion in China, occupying 80.2% of the IVD industry. Large-scale diagnostic reagent manufacturers are often good-sized medical test equipment producers as well, but many Chinese enterprises only deal with diagnostic reagents. In China, the high-end diagnostic instrument market is taken over by foreign brands, such as Hitachi, Toshiba, Olympus, Sysmex, etc. However, after years of rapid improvement in the field of diagnostic instrument, Kehua Bio-engineering (KHB) has become a leading domestic enterprise of diagnostic reagent and instrument.
  4. 4. <ul><li>3.6 Development Tendency of Diagnostic Reagent Sector in China </li></ul><ul><li>4. Major Domestic Producers </li></ul><ul><li>4.1 Shanghai Kehua Bio-Engineering </li></ul><ul><li>Co., Ltd. (KHB) </li></ul><ul><li>4.1.1 Profile </li></ul><ul><li>4.1.2 Operation </li></ul><ul><li>4.1.3 Diagnostic Reagent Business </li></ul><ul><li>4.1.4 Prospects and Dynamics </li></ul><ul><li>4.2 Da An Gene Co., Ltd. of Sun Yat-Sen University </li></ul><ul><li>4.2.1 Profile </li></ul><ul><li>4.2.2 Operation </li></ul><ul><li>4.2.3 Diagnostic Reagent Business </li></ul><ul><li>4.2.4 Prospects and Dynamics </li></ul><ul><li>4.3 Fosun Pharmaceutical (Group)Co., Ltd. </li></ul><ul><li>4.3.1 Profile </li></ul><ul><li>4.3.2 Operation </li></ul><ul><li>4.3.3 Prospects and Dynamics </li></ul><ul><li>4.3.4 Shanghai Fosun Long March Medical Science Co., Ltd. </li></ul><ul><li>4.3.5 Shanghai Fosun Med-Tech </li></ul><ul><li>Development Co., Ltd. </li></ul><ul><li>4.4 Biosino Bio-Technology & Science Inc. </li></ul><ul><li>4.4.1 Profile </li></ul><ul><li>4.4.2 Operation </li></ul><ul><li>4.4.3 Prospects and Dynamics </li></ul>1. Industry Profile 1.1 Definition and Classification 1.2 Industrial Chain 1.2.1 Upstream Market 1.2.2 Downstream Market 2. Operating Environment in China 2.1 Global Market 2.1.1 Development of Biopharmaceutical Industry Worldwide 2.1.2 Development of Diagnostic Reagent Industry Worldwide 2.2 Chinese Market 2.2.1 Development of Biopharmaceutical Industry in China 2.2.2 Relevant Policies of China 3. Development in China 3.1 Status Quo 3.2 Market Size 3.3 Competition Pattern 3.4 Import & Export 3.4.1 Import 3.4.2 Export 3.5 Market Segments 3.5.1 Biochemistry Diagnostic Reagent 3.5.2 Immune Diagnostic Reagent 3.5.3 Nucleic Acid Diagnostic Reagent Table of contents 4.5 Beijing Kinghawk Pharmaceutical Co., Ltd. 4.5.1 Profile 4.5.2 Operation 4.5.3 Prospects and Dynamics 4.6 Zhuhai Livzon Diagnostics Inc. 4.6.1 Profile 4.6.2 Operation 4.7 ACON Biotech (Hangzhou) Co., Ltd. 4.7.1 Profile 4.7.2 Operation 4.8 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 4.9 Shanghai Rongsheng Biotech Co., Ltd. 4.10 Shenzhen PG Biotech Co., Ltd. 4.10.1 Profile 4.10.2 Major Products 4.11 Shanghai Upper Bio-Tech Pharma Co., Ltd. 4.12 Beijing Leadman Biochemistry Co., Ltd. 4.12.1 Profile 4.12.2 Operation 4.12.3 Prospects and Dynamics 4.13 Blue Cross Bio-Medical (Beijing) Co., Ltd. 4.14 Inverness Medical (Shanghai)Co., Ltd. 4.15 Baso Diagnostics Inc. 4.16 Beijing North Institute of Biological Technology 4.17 Xiamen Boson Biotech Co., Ltd.
  5. 5. <ul><li>Global Biopharmaceutical Market Scale, 2007-2012 </li></ul><ul><li>Global Biopharmaceutical Revenue by Region, 2009 </li></ul><ul><li>Market Size of IVD Industry Worldwide, 2008-2012 </li></ul><ul><li>China’s Biopharmaceutical Sales and YoY Growth, 2005-Jan-May 2011 </li></ul><ul><li>Relevant Polices of Diagnostic Reagent Industry in China </li></ul><ul><li>Product Structure of Diagnostic Reagent Industry in China, 2010 </li></ul><ul><li>Structure of In Vitro Diagnostic Reagents in China, 2010 </li></ul><ul><li>Market Size and Growth Rate of In Vitro Diagnostic Industry in China, 2007-2014 </li></ul><ul><li>Market Size and Growth Rate of In Vitro Diagnostic Reagents in China, 2007-2014 </li></ul><ul><li>Major Manufacturers of IVD Products in China </li></ul><ul><li>China’s Import Value, Import Volume and Average Price of Contrast Agent for X-Ray Inspection and Diagnostic Reagent for Patients, 2007-Jan.-Aug. 2011 </li></ul><ul><li>China’s Accumulated Import Volume & Value and Proportion of Contrast Agent for X-Ray Inspection and Diagnostic Reagent for Patients by Country of Origin, Jan.-Aug. 2011 </li></ul><ul><li>Distribution of China’s Imported Contrast Agent for X-Ray Inspection and Diagnostic Reagent for Patients by Destination, 2008- Jan- Aug.2011 </li></ul><ul><li>China’s Export Value, Export Volume and Average Price of Contrast Agent for X-Ray Inspection and Diagnostic Reagent for Patients by Destination, 2007-Jan.-Aug. 2011 </li></ul><ul><li>China’s Accumulated Export Volume & Value and Proportion of Contrast Agent for X-Ray Inspection and Diagnostic Reagent for Patients by Destination, Jan.-Aug. 2011 </li></ul><ul><li>Export Origins Distribution of China’s Contrast Agent for X-Ray Inspection and Diagnostic Reagent for Patients, Jan.-Aug. 2011 </li></ul><ul><li>China’s Biochemical Reagent Market Scale, 2007-2014 </li></ul><ul><li>China’s Immune Reagent Market Scale, 2007-2014 </li></ul><ul><li>Operating Revenue and Net Income of KHB, 2006- H1 2011 </li></ul>Selected Charts
  6. 6. <ul><li>Gross Margin of KHB by Product, 2008-H1 2011 </li></ul><ul><li>Proportion of Operating Revenue of KHB by Region, 2008-H1 2011 </li></ul><ul><li>Diagnostic Reagent Products of KHB </li></ul><ul><li>Operating Revenue and Gross Margin of KHB, 2011-2013E </li></ul><ul><li>Operating Revenue and Net Income of Da An Gene, 2006- H1 2011 </li></ul><ul><li>Operating Revenue of Da An Gene by Product, 2007- H1 2011 </li></ul><ul><li>Gross Margin of Da An Gene by Product, 2008-H1 2011 </li></ul><ul><li>Proportion of Operating Revenue of Da An Gene by Region, 2008-H1 2011 </li></ul><ul><li>R&D Input and Its Ratio to Operating Revenue of Da An Gene, 2008-2010 </li></ul><ul><li>Operating Revenue and Gross Margin of Da An Gene, 2011-2013E </li></ul><ul><li>Operating Revenue and Net Income of Fosun Pharmaceutical (Group), 2006- H1 2011 </li></ul><ul><li>Operating Revenue and Gross Margin of Fosun Pharmaceutical (Group), 2011-2013E </li></ul><ul><li>Operation of Shanghai Fosun Long March Medical Science, 2008-2009 </li></ul><ul><li>Operation of Shanghai Fosun Med-Tech Development, 2008-2009 </li></ul><ul><li>Operating Revenue and Net Income of Biosino Bio-Technology & Science, 2006- H1 2011 </li></ul><ul><li>Operating Revenue of Biosino Bio-Technology & Science by Product, 2008- H1 2011 </li></ul><ul><li>Licenses and Patents for In-vitro Diagnostic Reagents of Biosino Bio-Technology& Science, 2010 </li></ul><ul><li>Operating Revenue and Net Income of Beijing Kinghawk Pharmaceutical, 2008- H1 2011 </li></ul><ul><li>Operating Revenue of Beijing Kinghawk Pharmaceutical (by Product), 2010- H1 2011 </li></ul><ul><li>Operating Revenue of Beijing Kinghawk Pharmaceutical (by Region), 2010- H1 2011 </li></ul><ul><li>Operating Revenue of Zhuhai Livzon Diagnostics, 2007- H1 2011 </li></ul><ul><li>Certificate Acquired by Zhuhai Livzon Diagnostics, Jun.2010-Sep.2011 </li></ul><ul><li>Operation of ACON Biotech, 2008-2009 </li></ul><ul><li>Certificate Acquired by ACON Biotech for the Registration of Medical Devices, Mar. 2010 & May 2011 </li></ul><ul><li>Operation of Beijing Wantai Biological Pharmacy, 2008-2009 </li></ul>Selected Charts
  7. 7. <ul><li>Operation of Shanghai Rongsheng Biotech, 2008-2009 </li></ul><ul><li>Operation of PG Biotech, 2008 </li></ul><ul><li>Detection Reagent of PG Biotech </li></ul><ul><li>Operation of Shanghai Upper Bio-Tech Pharma, 2008-2009 </li></ul><ul><li>Diagnostic Reagents and Diagnostic Instruments of Shanghai Upper Bio-Tech Pharma </li></ul><ul><li>Operation of Beijing Leadman Biochemistry, 2008-2009 </li></ul><ul><li>Operation of Blue Cross Bio-Medical (Beijing), 2008-2009 </li></ul><ul><li>Operation of Inverness Medical (Shanghai), 2008-2009 </li></ul><ul><li>Operation of Baso Diagnostics, 2008-2009 </li></ul><ul><li>Operation of Beijing North Institute of Biological Technology, 2008-2009 </li></ul><ul><li>Operation of Boson Biotech, 2009 </li></ul>Selected Charts
  8. 8. <ul><li>You can place your order in the following alternative ways: </li></ul><ul><li>Order online at www.researchinchina.com </li></ul><ul><li>Fax order sheet to us at fax number:+86 10 82601570 </li></ul><ul><li>3. Email your order to: [email_address] </li></ul><ul><li>4. Phone us at +86 10 82600828/ 82600893 </li></ul>Choose type of format Hard copy …………………………1600 USD PDF (Single user license) ………......1500 USD PDF (Enterprisewide license)….. ......2300 USD ※ Reports will be dispatched immediately once full payment has been received. Payment may be made by wire transfer or credit card via Paypal. Room 1008, A2, Tower A, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080 Phone: +86 10 82600828 ● Fax: +86 10 82601570 ● www.researchinchina.com ● [email_address] How to Buy Party A: Name: Address: Contact Person: Tel E-mail: Fax Party B: Name: Beijing Waterwood Technologies Co., Ltd (ResearchInChina) Address: Room 1008, A2, Tower A, Changyuan Tiandi Building, No. 18, Suzhou Street, Haidian District, Beijing, China 100080 Contact Person: Liao Yan Phone: 86-10-82600828 E-mail: [email_address] Fax: 86-10-82601570 Bank details: Beneficial Name: Beijing Waterwood Technologies Co., Ltd Bank Name: Bank of Communications, Beijing Branch Bank Address: NO.1 jinxiyuan shijicheng,Landianchang,Haidian District,Beijing Bank Account No #: 110060668012015061217 Routing No # : 332906 Bank SWIFT Code: COMMCNSHBJG Title Format Cost Total

×